Skip to content

A randomized controlled study on the efficacy and safety of enhanced recovery after surgery in gynecological transvaginal natural-orifice transluminal endoscopic surgery

A randomized controlled study on the efficacy and safety of enhanced recovery after surgery in gynecological transvaginal natural-orifice transluminal endoscopic surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042458
Enrollment
Unknown
Registered
2021-01-21
Start date
2021-01-21
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign gynecological diseases

Interventions

control group:Nil

Sponsors

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) The age ranged from 18 to 60 years; 2) Women with sexual life history; 3) Patients with benign gynecological diseases need surgical treatment; 4) The vital signs are stable and can tolerate endoscopic surgery; 5) Patients were able to understand the protocol and willing to participate in the study, and provided written informed consent.

Exclusion criteria

Exclusion criteria: 1) Pregnant women; 2) The diameter of adnexal mass was larger than 8-10 cm, the uterine enlargement was larger than that of 3-month pregnancy; 3) Patients with previous history of pelvic inflammatory disease and pelvic adhesion; 4) Patients with pelvic endometriosis; 5) There was a history of multiple pelvic and abdominal surgery (cesarean section more than 2 times); 6) Patients with vaginitis symptoms or without improvement after treatment; 7) Patients with palpable or suspicious uterine rectal fossa closure, nodule or scar, and vaginal stenosis; 8) The presence of mental illness or drug abuse that may affect compliance with the trial requirements is known;

Design outcomes

Primary

MeasureTime frame
Operation time;Anesthesia time;volum of bleeding during operation;Operative complications;Postoperative pain score;The time of first sexual intercourse after operation;Sexual satisfaction;Inflammatory cytokines and immune factors, etc;

Secondary

MeasureTime frame
The use of analgesics;Exsufflation time after operation;The time of urination and defecation was restored after operation;The time of getting out of bed for the first time after operation;Postoperative nausea / vomiting;Satisfaction of postoperative quality of life;Length of stay;Hospitalization expenses;Wound recovery 1 month after operation;

Countries

China

Contacts

Public ContactYin Chen

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China

107276018@qq.com+8613981815307

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026